How big is the Hydroxyapatite Market:

The latest research study "Hydroxyapatite Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" by IMARC Group, finds that The global hydroxyapatite market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

What are Hydroxyapatite?

Hydroxyapatite (Ca10(PO4)6(OH)2) is an inorganic calcium phosphate mineral found in nature. It is derived from various biological origins, such as mammalian bones, fish scales, eggshells, and more. This mineral closely resembles the structure and composition of hard tissues. It exhibits a hexagonal structure and possesses a serum calcium to phosphorus (Ca/P) ratio that mirrors that of bone apatite. Unlike calcium phosphates, hydroxyapatite can remain thermodynamically stable under several temperature and pH levels. Hydroxyapatite offers high rigidity, better enamel remineralization than saliva, faster bone healing at the bone-implant interface, compositional closeness to bone minerals, etc. Consequently, it is extensively used in coatings to coarsen metal implant surfaces, bone grafts or fillers, orthopedic and dental care devices, etc. Presently, hydroxyapatite is commonly bifurcated into nano and micro-sized types.

Request a free sample brochure: https://www.imarcgroup.com/hydroxyapatite-market/requestsample

What are the growth prospects and trends in the Hydroxyapatite industry:

The increasing incidence of cardiovascular diseases (CVDs) and the rising demand for applications like bone grafting, transplants, and bioactive ceramics are primary drivers propelling the hydroxyapatite market. Additionally, heightened consumer awareness regarding physical appearance and the escalating prevalence of dermatological concerns, particularly among the elderly population, are contributing significantly to the market's growth. Moreover, the widespread adoption of nano-hydroxyapatite in drug and gene delivery, bone tissue engineering and fillers, and as a desensitizing agent to decrease tooth sensitivity and reduce plaque levels for teeth whitening is positively influencing the global market. Besides this, various benefits associated with hydroxyapatite, such as bioactivity, osteoconductive, non-toxicity, and non-inflammatory properties, are also propelling the market growth. Furthermore, it is gaining extensive popularity as a fluoride substitute, which is expected to fuel the hydroxyapatite market over the forecasted period.

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• APS Materials Inc.

• Berkeley Advanced Biomaterials

• Bio-Rad Laboratories Inc.

• CAM Bioceramics B.V.

• Cgbio, Fluidinova S.A.

• HOYA Technosurgical Corporation (Hoya Corporation)

• Medtronic plc

• Merz Pharma GmbH & Co. KGaA

• SigmaGraft Biomaterials

• SofSera Corporation

• Taihei Chemical Industrial Co. Ltd. 

• Zimmer Biomet.

What is included in market segmentation?

Breakup by Type:

• Nano-sized

• Micro-sized

• Greater than Micrometer

Breakup by Application:

• Orthopedic

• Dental Care

• Plastic Surgery

• Others

By Geography:

• North America: (United States, Canada)

• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico, Others)

• Middle East and Africa

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/